

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 7.10451881 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 7.10451881 |
| 3 | endothelium development (GO:0003158) | 6.46261715 |
| 4 | glucose 6-phosphate metabolic process (GO:0051156) | 6.38442236 |
| 5 | protein maturation by protein folding (GO:0022417) | 6.32325553 |
| 6 | definitive hemopoiesis (GO:0060216) | 6.19433954 |
| 7 | endocrine pancreas development (GO:0031018) | 5.80186899 |
| 8 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 5.78172888 |
| 9 | nuclear pore complex assembly (GO:0051292) | 5.76960805 |
| 10 | COPII vesicle coating (GO:0048208) | 5.70977341 |
| 11 | positive regulation of vasculogenesis (GO:2001214) | 5.47565131 |
| 12 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 5.43287251 |
| 13 | peptide hormone processing (GO:0016486) | 5.31801660 |
| 14 | nuclear pore organization (GO:0006999) | 5.25699503 |
| 15 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 5.11970086 |
| 16 | sequestering of metal ion (GO:0051238) | 5.05470943 |
| 17 | signal peptide processing (GO:0006465) | 4.93772546 |
| 18 | glandular epithelial cell differentiation (GO:0002067) | 4.61248877 |
| 19 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.56894770 |
| 20 | nerve growth factor signaling pathway (GO:0038180) | 4.54770427 |
| 21 | regulation of histone H3-K9 methylation (GO:0051570) | 4.48901810 |
| 22 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.44717265 |
| 23 | Rap protein signal transduction (GO:0032486) | 4.30374169 |
| 24 | regulation of vasculogenesis (GO:2001212) | 4.22834511 |
| 25 | pore complex assembly (GO:0046931) | 4.17552585 |
| 26 | detection of calcium ion (GO:0005513) | 4.16673709 |
| 27 | thrombin receptor signaling pathway (GO:0070493) | 4.16466240 |
| 28 | positive regulation of insulin secretion (GO:0032024) | 4.12970256 |
| 29 | insulin secretion (GO:0030073) | 4.05455613 |
| 30 | DNA unwinding involved in DNA replication (GO:0006268) | 4.02105958 |
| 31 | type B pancreatic cell development (GO:0003323) | 3.95038893 |
| 32 | IMP metabolic process (GO:0046040) | 3.93216971 |
| 33 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.90987304 |
| 34 | protein retention in ER lumen (GO:0006621) | 3.86555505 |
| 35 | IMP biosynthetic process (GO:0006188) | 3.86349508 |
| 36 | exocrine pancreas development (GO:0031017) | 3.76594129 |
| 37 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.74111912 |
| 38 | regulation of insulin secretion (GO:0050796) | 3.67199668 |
| 39 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.63988417 |
| 40 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.63988417 |
| 41 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.61938566 |
| 42 | glycoside metabolic process (GO:0016137) | 3.60663945 |
| 43 | glandular epithelial cell development (GO:0002068) | 3.57572452 |
| 44 | vesicle coating (GO:0006901) | 3.57361684 |
| 45 | pre-miRNA processing (GO:0031054) | 3.55034336 |
| 46 | DNA topological change (GO:0006265) | 3.54813363 |
| 47 | granulocyte differentiation (GO:0030851) | 3.47840174 |
| 48 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.44935695 |
| 49 | negative regulation of neurotransmitter transport (GO:0051589) | 3.42932692 |
| 50 | negative regulation of histone methylation (GO:0031061) | 3.41971132 |
| 51 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.39116845 |
| 52 | DNA replication checkpoint (GO:0000076) | 3.38166602 |
| 53 | mitotic G2/M transition checkpoint (GO:0044818) | 3.36761192 |
| 54 | positive regulation of glycolytic process (GO:0045821) | 3.36669999 |
| 55 | cellular zinc ion homeostasis (GO:0006882) | 3.35731809 |
| 56 | positive regulation of peptide hormone secretion (GO:0090277) | 3.35308485 |
| 57 | regulation of peptide hormone secretion (GO:0090276) | 3.34438474 |
| 58 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.33928174 |
| 59 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.33768971 |
| 60 | mitotic sister chromatid cohesion (GO:0007064) | 3.33377393 |
| 61 | regulation of oxidative phosphorylation (GO:0002082) | 3.30885093 |
| 62 | toxin metabolic process (GO:0009404) | 3.29441277 |
| 63 | positive regulation of nuclease activity (GO:0032075) | 3.28358580 |
| 64 | regulation of peptide secretion (GO:0002791) | 3.27617450 |
| 65 | positive regulation of peptide secretion (GO:0002793) | 3.23016159 |
| 66 | atrial cardiac muscle cell action potential (GO:0086014) | 3.22842246 |
| 67 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.22787954 |
| 68 | gap junction assembly (GO:0016264) | 3.21401882 |
| 69 | ER overload response (GO:0006983) | 3.17050336 |
| 70 | erythrocyte maturation (GO:0043249) | 3.16563316 |
| 71 | regulation of hexokinase activity (GO:1903299) | 3.14754747 |
| 72 | regulation of glucokinase activity (GO:0033131) | 3.14754747 |
| 73 | mitotic G2 DNA damage checkpoint (GO:0007095) | 3.13419180 |
| 74 | alkaloid metabolic process (GO:0009820) | 3.13041661 |
| 75 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.12601639 |
| 76 | cellular response to nicotine (GO:0071316) | 3.10957942 |
| 77 | megakaryocyte development (GO:0035855) | 3.10520632 |
| 78 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.08177716 |
| 79 | L-phenylalanine catabolic process (GO:0006559) | 3.08177716 |
| 80 | DNA double-strand break processing (GO:0000729) | 3.03937401 |
| 81 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.02434478 |
| 82 | lactate metabolic process (GO:0006089) | 3.01997340 |
| 83 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.01751324 |
| 84 | response to UV-C (GO:0010225) | 3.01284257 |
| 85 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.01245436 |
| 86 | negative regulation of insulin secretion (GO:0046676) | 2.97320005 |
| 87 | purine nucleobase biosynthetic process (GO:0009113) | 2.96939285 |
| 88 | regulation of nuclease activity (GO:0032069) | 2.96779978 |
| 89 | regulation of chromatin silencing (GO:0031935) | 2.93538767 |
| 90 | protein neddylation (GO:0045116) | 2.93131140 |
| 91 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.92806020 |
| 92 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.92806020 |
| 93 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.92500299 |
| 94 | glucose homeostasis (GO:0042593) | 2.92012930 |
| 95 | carbohydrate homeostasis (GO:0033500) | 2.92012930 |
| 96 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.91276708 |
| 97 | regulation of RNA export from nucleus (GO:0046831) | 2.91266010 |
| 98 | peroxisome fission (GO:0016559) | 2.91254390 |
| 99 | rRNA methylation (GO:0031167) | 2.89363311 |
| 100 | carbohydrate phosphorylation (GO:0046835) | 2.89342891 |
| 101 | regulation of energy homeostasis (GO:2000505) | 2.88875471 |
| 102 | regulation of centriole replication (GO:0046599) | 2.87665658 |
| 103 | fatty acid homeostasis (GO:0055089) | 2.86488198 |
| 104 | response to hexose (GO:0009746) | 2.85475564 |
| 105 | cellular response to unfolded protein (GO:0034620) | 2.85024839 |
| 106 | * regulation of hormone secretion (GO:0046883) | 2.84352665 |
| 107 | peptide hormone secretion (GO:0030072) | 2.83869161 |
| 108 | macroautophagy (GO:0016236) | 2.83684725 |
| 109 | hematopoietic stem cell differentiation (GO:0060218) | 2.83154894 |
| 110 | ER-nucleus signaling pathway (GO:0006984) | 2.82998048 |
| 111 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.82803178 |
| 112 | tyrosine metabolic process (GO:0006570) | 2.82091882 |
| 113 | nucleoside diphosphate catabolic process (GO:0009134) | 2.82050184 |
| 114 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.81101633 |
| 115 | L-phenylalanine metabolic process (GO:0006558) | 2.81101633 |
| 116 | DNA geometric change (GO:0032392) | 2.79737372 |
| 117 | peptide secretion (GO:0002790) | 2.79371970 |
| 118 | response to glucose (GO:0009749) | 2.79155699 |
| 119 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 2.78745212 |
| 120 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 2.78745212 |
| 121 | nucleoside bisphosphate metabolic process (GO:0033865) | 2.78745212 |
| 122 | DNA duplex unwinding (GO:0032508) | 2.78527357 |
| 123 | skeletal muscle tissue regeneration (GO:0043403) | 2.78303932 |
| 124 | regulation of establishment of cell polarity (GO:2000114) | 2.76216386 |
| 125 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.76082167 |
| 126 | ether lipid metabolic process (GO:0046485) | 2.75841550 |
| 127 | negative regulation of heart rate (GO:0010459) | 2.75163797 |
| 128 | intestinal cholesterol absorption (GO:0030299) | 2.74260418 |
| 129 | keratinization (GO:0031424) | 2.72800717 |
| 130 | cellular response to topologically incorrect protein (GO:0035967) | 2.71745315 |
| 131 | tricarboxylic acid metabolic process (GO:0072350) | 2.70968277 |
| 132 | response to monosaccharide (GO:0034284) | 2.70810137 |
| 133 | cellular response to glucagon stimulus (GO:0071377) | 2.70091864 |
| 134 | 4-hydroxyproline metabolic process (GO:0019471) | 2.69239518 |
| 135 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.68968943 |
| 136 | regulation of peptide transport (GO:0090087) | 2.68915750 |
| 137 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.68740041 |
| 138 | protein localization to Golgi apparatus (GO:0034067) | 2.68661660 |
| 139 | chromatin remodeling at centromere (GO:0031055) | 2.67268186 |
| 140 | intestinal absorption (GO:0050892) | 2.67167107 |
| 141 | peripheral nervous system neuron development (GO:0048935) | 2.65928340 |
| 142 | nitric oxide mediated signal transduction (GO:0007263) | 2.65648543 |
| 143 | CENP-A containing nucleosome assembly (GO:0034080) | 2.65243476 |
| 144 | negative regulation of blood circulation (GO:1903523) | 2.64898252 |
| 145 | cytidine metabolic process (GO:0046087) | 2.64180280 |
| 146 | cytidine catabolic process (GO:0006216) | 2.64180280 |
| 147 | cytidine deamination (GO:0009972) | 2.64180280 |
| 148 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.63174690 |
| 149 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.63174690 |
| 150 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.62714484 |
| 151 | norepinephrine metabolic process (GO:0042415) | 2.62566690 |
| 152 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.62026310 |
| 153 | membrane repolarization (GO:0086009) | 2.61405837 |
| 154 | negative regulation of sister chromatid segregation (GO:0033046) | 2.60715890 |
| 155 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.60715890 |
| 156 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.60715890 |
| 157 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.60715890 |
| 158 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.60715890 |
| 159 | positive regulation of Rap GTPase activity (GO:0032854) | 2.58832159 |
| 160 | erythrocyte development (GO:0048821) | 2.58411893 |
| 161 | positive regulation of steroid hormone secretion (GO:2000833) | 2.58212257 |
| 162 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.58097087 |
| 163 | establishment of skin barrier (GO:0061436) | 2.57641692 |
| 164 | regulation of histone H3-K4 methylation (GO:0051569) | 2.56794236 |
| 165 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.55997776 |
| 166 | DNA replication initiation (GO:0006270) | 2.55877535 |
| 167 | nodal signaling pathway (GO:0038092) | 2.55282386 |
| 168 | synapsis (GO:0007129) | 2.54039219 |
| 169 | regulation of pigment cell differentiation (GO:0050932) | 2.53444159 |
| 170 | positive regulation of histone methylation (GO:0031062) | 2.53440825 |
| 171 | negative regulation of chromosome segregation (GO:0051985) | 2.53313903 |
| 172 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.52824832 |
| 173 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.52824832 |
| 174 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.52805500 |
| 175 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.51846782 |
| 176 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.51846782 |
| 177 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.51553356 |
| 178 | negative regulation of DNA recombination (GO:0045910) | 2.50777832 |
| 179 | early endosome to late endosome transport (GO:0045022) | 2.50405511 |
| 180 | regulation of sister chromatid segregation (GO:0033045) | 2.47923280 |
| 181 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.47923280 |
| 182 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.47923280 |
| 183 | embryonic process involved in female pregnancy (GO:0060136) | 2.47653745 |
| 184 | positive regulation of developmental pigmentation (GO:0048087) | 2.46950805 |
| 185 | embryonic hemopoiesis (GO:0035162) | 2.46241616 |
| 186 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.46169488 |
| 187 | DNA replication-independent nucleosome organization (GO:0034724) | 2.45178338 |
| 188 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.45178338 |
| 189 | mitotic nuclear envelope disassembly (GO:0007077) | 2.45016466 |
| 190 | prenylation (GO:0097354) | 2.44796931 |
| 191 | protein prenylation (GO:0018342) | 2.44796931 |
| 192 | ribosome assembly (GO:0042255) | 2.44641493 |
| 193 | histone exchange (GO:0043486) | 2.44414215 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.00206375 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.41955816 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 4.63980407 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.24975469 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.06109458 |
| 6 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.02920812 |
| 7 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.87431596 |
| 8 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.79412467 |
| 9 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.70830374 |
| 10 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.54447177 |
| 11 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.52507603 |
| 12 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.42780797 |
| 13 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.34525035 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.29807931 |
| 15 | FUS_26573619_Chip-Seq_HEK293_Human | 2.25658875 |
| 16 | EWS_26573619_Chip-Seq_HEK293_Human | 2.23151212 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.99771208 |
| 18 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.98969994 |
| 19 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.95952970 |
| 20 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88237480 |
| 21 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.86524429 |
| 22 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.85971412 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.84026641 |
| 24 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.78942120 |
| 25 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.70954581 |
| 26 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.64422345 |
| 27 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.64067916 |
| 28 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.63802024 |
| 29 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.59609657 |
| 30 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.54986397 |
| 31 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.50115884 |
| 32 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.50115884 |
| 33 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.50115884 |
| 34 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.49183307 |
| 35 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.48122636 |
| 36 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.47533098 |
| 37 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.46398189 |
| 38 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.46135541 |
| 39 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.45642814 |
| 40 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.42578842 |
| 41 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.42518369 |
| 42 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41928184 |
| 43 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.39053620 |
| 44 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.38710522 |
| 45 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.38424230 |
| 46 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36607185 |
| 47 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.34181336 |
| 48 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.33706417 |
| 49 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32898769 |
| 50 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.31889723 |
| 51 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.29867505 |
| 52 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.28511244 |
| 53 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.27705960 |
| 54 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.27134153 |
| 55 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.26189489 |
| 56 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.25358866 |
| 57 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.24756587 |
| 58 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.23996288 |
| 59 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.23856382 |
| 60 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.23747321 |
| 61 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.22680371 |
| 62 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20801498 |
| 63 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.20780710 |
| 64 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.20729896 |
| 65 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20717520 |
| 66 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.20172085 |
| 67 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.18596560 |
| 68 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.18533419 |
| 69 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.18127201 |
| 70 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17303832 |
| 71 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.16863482 |
| 72 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16767098 |
| 73 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.16418331 |
| 74 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.14965529 |
| 75 | VDR_22108803_ChIP-Seq_LS180_Human | 1.14554985 |
| 76 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.14396806 |
| 77 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.13892495 |
| 78 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.13600086 |
| 79 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.13104865 |
| 80 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12702776 |
| 81 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.12273654 |
| 82 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11736273 |
| 83 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.11727457 |
| 84 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.10986203 |
| 85 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.10619861 |
| 86 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.09665869 |
| 87 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.09645081 |
| 88 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.08784173 |
| 89 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.07921545 |
| 90 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.07813687 |
| 91 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.07753284 |
| 92 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.07256538 |
| 93 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06131599 |
| 94 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06087697 |
| 95 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.03813160 |
| 96 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.02766466 |
| 97 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.01935252 |
| 98 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.01765374 |
| 99 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.01614619 |
| 100 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.01446991 |
| 101 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01417364 |
| 102 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.01237647 |
| 103 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.00518253 |
| 104 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.00285660 |
| 105 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00196310 |
| 106 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00167578 |
| 107 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.00119012 |
| 108 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.00005293 |
| 109 | NFYB_21822215_ChIP-Seq_K562_Human | 0.99290855 |
| 110 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98580775 |
| 111 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.98450648 |
| 112 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.98323091 |
| 113 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.97833958 |
| 114 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.97816739 |
| 115 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97566238 |
| 116 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97421648 |
| 117 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94939833 |
| 118 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94866099 |
| 119 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.94467145 |
| 120 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.93764106 |
| 121 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.92975523 |
| 122 | AR_20517297_ChIP-Seq_VCAP_Human | 0.92933466 |
| 123 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92758963 |
| 124 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.92637454 |
| 125 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.92297199 |
| 126 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.92222891 |
| 127 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.91707705 |
| 128 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.91555041 |
| 129 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.91134661 |
| 130 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.91047287 |
| 131 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90942234 |
| 132 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.90730615 |
| 133 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.90364565 |
| 134 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.90351726 |
| 135 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89834195 |
| 136 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89034321 |
| 137 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.89034321 |
| 138 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88585759 |
| 139 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.88573652 |
| 140 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.88520784 |
| 141 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.88469804 |
| 142 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88446266 |
| 143 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.88107495 |
| 144 | TBL1_22424771_ChIP-Seq_293T_Human | 0.87793137 |
| 145 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.87726851 |
| 146 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.87534818 |
| 147 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.87520249 |
| 148 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.87422928 |
| 149 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.86740669 |
| 150 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.86389993 |
| 151 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.85739834 |
| 152 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.85672774 |
| 153 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.84564429 |
| 154 | STAT3_23295773_ChIP-Seq_U87_Human | 0.83924673 |
| 155 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83249603 |
| 156 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.83060807 |
| 157 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.82654923 |
| 158 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.81828079 |
| 159 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.81752823 |
| 160 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81622234 |
| 161 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.80887770 |
| 162 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80441999 |
| 163 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.79559378 |
| 164 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.79559378 |
| 165 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.79016171 |
| 166 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79002516 |
| 167 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.78627097 |
| 168 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.78260680 |
| 169 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.77567307 |
| 170 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.77459639 |
| 171 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.77389978 |
| 172 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76961949 |
| 173 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76961949 |
| 174 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.76804654 |
| 175 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75407733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 4.77402839 |
| 2 | MP0008057_abnormal_DNA_replication | 4.46020655 |
| 3 | MP0009780_abnormal_chondrocyte_physiolo | 4.09022594 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 3.67389235 |
| 5 | MP0002693_abnormal_pancreas_physiology | 3.62283027 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 3.55381137 |
| 7 | MP0003183_abnormal_peptide_metabolism | 3.53326452 |
| 8 | MP0003283_abnormal_digestive_organ | 3.50601947 |
| 9 | MP0004043_abnormal_pH_regulation | 3.39578751 |
| 10 | MP0004147_increased_porphyrin_level | 3.34842330 |
| 11 | MP0005365_abnormal_bile_salt | 3.08061598 |
| 12 | MP0001944_abnormal_pancreas_morphology | 3.07217294 |
| 13 | MP0002909_abnormal_adrenal_gland | 2.91805357 |
| 14 | MP0005464_abnormal_platelet_physiology | 2.89175980 |
| 15 | MP0003195_calcinosis | 2.88109106 |
| 16 | MP0005379_endocrine/exocrine_gland_phen | 2.84589324 |
| 17 | MP0010352_gastrointestinal_tract_polyps | 2.75786743 |
| 18 | MP0002009_preneoplasia | 2.73461650 |
| 19 | MP0005085_abnormal_gallbladder_physiolo | 2.68045980 |
| 20 | MP0004957_abnormal_blastocyst_morpholog | 2.64682902 |
| 21 | MP0002796_impaired_skin_barrier | 2.55871763 |
| 22 | MP0010386_abnormal_urinary_bladder | 2.46392523 |
| 23 | MP0000013_abnormal_adipose_tissue | 2.46239670 |
| 24 | MP0005083_abnormal_biliary_tract | 2.45378105 |
| 25 | MP0001986_abnormal_taste_sensitivity | 2.42006153 |
| 26 | MP0010234_abnormal_vibrissa_follicle | 2.40273980 |
| 27 | MP0003890_abnormal_embryonic-extraembry | 2.39361879 |
| 28 | MP0010094_abnormal_chromosome_stability | 2.38119264 |
| 29 | MP0005646_abnormal_pituitary_gland | 2.35057254 |
| 30 | MP0002078_abnormal_glucose_homeostasis | 2.31276696 |
| 31 | MP0003111_abnormal_nucleus_morphology | 2.29335696 |
| 32 | MP0002638_abnormal_pupillary_reflex | 2.29137959 |
| 33 | MP0001188_hyperpigmentation | 2.23310071 |
| 34 | MP0004084_abnormal_cardiac_muscle | 2.17884467 |
| 35 | MP0005220_abnormal_exocrine_pancreas | 2.16363737 |
| 36 | MP0003941_abnormal_skin_development | 2.15994617 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 2.14484782 |
| 38 | MP0003718_maternal_effect | 2.11099580 |
| 39 | MP0008058_abnormal_DNA_repair | 2.07011707 |
| 40 | MP0001730_embryonic_growth_arrest | 1.96252819 |
| 41 | MP0002396_abnormal_hematopoietic_system | 1.95780866 |
| 42 | MP0001666_abnormal_nutrient_absorption | 1.86990871 |
| 43 | MP0000678_abnormal_parathyroid_gland | 1.86579376 |
| 44 | MP0002928_abnormal_bile_duct | 1.83098258 |
| 45 | MP0003693_abnormal_embryo_hatching | 1.82933176 |
| 46 | MP0003252_abnormal_bile_duct | 1.81315287 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.78646918 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.78646918 |
| 49 | MP0002138_abnormal_hepatobiliary_system | 1.71539983 |
| 50 | MP0005360_urolithiasis | 1.71361494 |
| 51 | MP0008961_abnormal_basal_metabolism | 1.67757763 |
| 52 | MP0003077_abnormal_cell_cycle | 1.64796436 |
| 53 | MP0009672_abnormal_birth_weight | 1.62206163 |
| 54 | MP0001270_distended_abdomen | 1.61283524 |
| 55 | MP0003300_gastrointestinal_ulcer | 1.58203976 |
| 56 | MP0005501_abnormal_skin_physiology | 1.57998423 |
| 57 | MP0005380_embryogenesis_phenotype | 1.57264460 |
| 58 | MP0001672_abnormal_embryogenesis/_devel | 1.57264460 |
| 59 | MP0002086_abnormal_extraembryonic_tissu | 1.53406436 |
| 60 | MP0003984_embryonic_growth_retardation | 1.52972992 |
| 61 | MP0008932_abnormal_embryonic_tissue | 1.52272371 |
| 62 | MP0005058_abnormal_lysosome_morphology | 1.51661467 |
| 63 | MP0000462_abnormal_digestive_system | 1.49148330 |
| 64 | MP0002088_abnormal_embryonic_growth/wei | 1.47607510 |
| 65 | MP0008875_abnormal_xenobiotic_pharmacok | 1.45738234 |
| 66 | MP0005535_abnormal_body_temperature | 1.44729723 |
| 67 | MP0009840_abnormal_foam_cell | 1.44189412 |
| 68 | MP0010678_abnormal_skin_adnexa | 1.43351364 |
| 69 | MP0009643_abnormal_urine_homeostasis | 1.43328915 |
| 70 | MP0002084_abnormal_developmental_patter | 1.41649436 |
| 71 | MP0010307_abnormal_tumor_latency | 1.41404830 |
| 72 | MP0003221_abnormal_cardiomyocyte_apopto | 1.40136471 |
| 73 | MP0001697_abnormal_embryo_size | 1.36875156 |
| 74 | MP0002118_abnormal_lipid_homeostasis | 1.36482303 |
| 75 | MP0005187_abnormal_penis_morphology | 1.35493476 |
| 76 | MP0003567_abnormal_fetal_cardiomyocyte | 1.34616355 |
| 77 | MP0010329_abnormal_lipoprotein_level | 1.34366298 |
| 78 | MP0003868_abnormal_feces_composition | 1.34353841 |
| 79 | MP0005636_abnormal_mineral_homeostasis | 1.33765998 |
| 80 | MP0002733_abnormal_thermal_nociception | 1.31938441 |
| 81 | MP0005647_abnormal_sex_gland | 1.30035922 |
| 82 | MP0000383_abnormal_hair_follicle | 1.27418563 |
| 83 | MP0002163_abnormal_gland_morphology | 1.27345597 |
| 84 | MP0003953_abnormal_hormone_level | 1.26694563 |
| 85 | MP0002735_abnormal_chemical_nociception | 1.26219727 |
| 86 | MP0008775_abnormal_heart_ventricle | 1.26022723 |
| 87 | MP0009703_decreased_birth_body | 1.25593693 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 1.25107509 |
| 89 | MP0004808_abnormal_hematopoietic_stem | 1.23672639 |
| 90 | MP0000613_abnormal_salivary_gland | 1.23029057 |
| 91 | MP0000350_abnormal_cell_proliferation | 1.21647583 |
| 92 | MP0004264_abnormal_extraembryonic_tissu | 1.21149575 |
| 93 | MP0003866_abnormal_defecation | 1.20297247 |
| 94 | MP0006036_abnormal_mitochondrial_physio | 1.17060704 |
| 95 | MP0004484_altered_response_of | 1.15947811 |
| 96 | MP0008007_abnormal_cellular_replicative | 1.13569943 |
| 97 | MP0002080_prenatal_lethality | 1.13568785 |
| 98 | MP0001727_abnormal_embryo_implantation | 1.12021421 |
| 99 | MP0003828_pulmonary_edema | 1.11217192 |
| 100 | MP0008877_abnormal_DNA_methylation | 1.11207287 |
| 101 | MP0001765_abnormal_ion_homeostasis | 1.10986945 |
| 102 | MP0010630_abnormal_cardiac_muscle | 1.10972641 |
| 103 | MP0002876_abnormal_thyroid_physiology | 1.10911391 |
| 104 | MP0008995_early_reproductive_senescence | 1.10560278 |
| 105 | MP0006072_abnormal_retinal_apoptosis | 1.09856996 |
| 106 | MP0000230_abnormal_systemic_arterial | 1.09377962 |
| 107 | MP0000609_abnormal_liver_physiology | 1.06977969 |
| 108 | MP0004145_abnormal_muscle_electrophysio | 1.06521048 |
| 109 | MP0004270_analgesia | 1.05892889 |
| 110 | MP0003123_paternal_imprinting | 1.05803585 |
| 111 | MP0000681_abnormal_thyroid_gland | 1.05259573 |
| 112 | MP0005385_cardiovascular_system_phenoty | 1.04893157 |
| 113 | MP0001544_abnormal_cardiovascular_syste | 1.04893157 |
| 114 | MP0000003_abnormal_adipose_tissue | 1.04719885 |
| 115 | MP0004885_abnormal_endolymph | 1.03699984 |
| 116 | MP0001879_abnormal_lymphatic_vessel | 1.02401469 |
| 117 | MP0000579_abnormal_nail_morphology | 1.01945049 |
| 118 | MP0001784_abnormal_fluid_regulation | 1.01634853 |
| 119 | MP0005448_abnormal_energy_balance | 1.01412073 |
| 120 | MP0004197_abnormal_fetal_growth/weight/ | 1.00498120 |
| 121 | MP0002896_abnormal_bone_mineralization | 1.00239168 |
| 122 | MP0001915_intracranial_hemorrhage | 0.99095002 |
| 123 | MP0001970_abnormal_pain_threshold | 0.98536294 |
| 124 | MP0006138_congestive_heart_failure | 0.98221619 |
| 125 | MP0000537_abnormal_urethra_morphology | 0.98171644 |
| 126 | MP0004185_abnormal_adipocyte_glucose | 0.97808691 |
| 127 | MP0004036_abnormal_muscle_relaxation | 0.96810838 |
| 128 | MP0002085_abnormal_embryonic_tissue | 0.96640763 |
| 129 | MP0002234_abnormal_pharynx_morphology | 0.96524115 |
| 130 | MP0005334_abnormal_fat_pad | 0.95729916 |
| 131 | MP0005167_abnormal_blood-brain_barrier | 0.94359503 |
| 132 | MP0000313_abnormal_cell_death | 0.93731000 |
| 133 | MP0003453_abnormal_keratinocyte_physiol | 0.92546807 |
| 134 | MP0005310_abnormal_salivary_gland | 0.91878608 |
| 135 | MP0003136_yellow_coat_color | 0.91712177 |
| 136 | MP0005620_abnormal_muscle_contractility | 0.91196479 |
| 137 | MP0009697_abnormal_copulation | 0.90842589 |
| 138 | MP0006054_spinal_hemorrhage | 0.90521382 |
| 139 | MP0004130_abnormal_muscle_cell | 0.89000217 |
| 140 | MP0008004_abnormal_stomach_pH | 0.88993320 |
| 141 | MP0000647_abnormal_sebaceous_gland | 0.88345788 |
| 142 | MP0000538_abnormal_urinary_bladder | 0.88246649 |
| 143 | MP0000266_abnormal_heart_morphology | 0.87986704 |
| 144 | MP0000749_muscle_degeneration | 0.87692803 |
| 145 | MP0009642_abnormal_blood_homeostasis | 0.87417874 |
| 146 | MP0005408_hypopigmentation | 0.86986066 |
| 147 | MP0000428_abnormal_craniofacial_morphol | 0.86129714 |
| 148 | MP0002090_abnormal_vision | 0.85537105 |
| 149 | MP0003172_abnormal_lysosome_physiology | 0.85429793 |
| 150 | MP0006035_abnormal_mitochondrial_morpho | 0.85172130 |
| 151 | MP0001191_abnormal_skin_condition | 0.84534679 |
| 152 | MP0001346_abnormal_lacrimal_gland | 0.84149562 |
| 153 | MP0003045_fibrosis | 0.83228897 |
| 154 | MP0005645_abnormal_hypothalamus_physiol | 0.82942996 |
| 155 | MP0003943_abnormal_hepatobiliary_system | 0.82796767 |
| 156 | MP0001502_abnormal_circadian_rhythm | 0.82540598 |
| 157 | MP0002095_abnormal_skin_pigmentation | 0.80362759 |
| 158 | MP0004215_abnormal_myocardial_fiber | 0.80254762 |
| 159 | MP0002925_abnormal_cardiovascular_devel | 0.79965659 |
| 160 | MP0002102_abnormal_ear_morphology | 0.79346897 |
| 161 | MP0001661_extended_life_span | 0.79336777 |
| 162 | MP0003879_abnormal_hair_cell | 0.78797351 |
| 163 | MP0001984_abnormal_olfaction | 0.78710573 |
| 164 | MP0002111_abnormal_tail_morphology | 0.78363859 |
| 165 | MP0003806_abnormal_nucleotide_metabolis | 0.77210522 |
| 166 | MP0001756_abnormal_urination | 0.77045699 |
| 167 | MP0005084_abnormal_gallbladder_morpholo | 0.75171276 |
| 168 | MP0004272_abnormal_basement_membrane | 0.75027955 |
| 169 | MP0003191_abnormal_cellular_cholesterol | 0.74833297 |
| 170 | MP0003937_abnormal_limbs/digits/tail_de | 0.74354608 |
| 171 | MP0001664_abnormal_digestion | 0.73169725 |
| 172 | MP0002734_abnormal_mechanical_nocicepti | 0.72664466 |
| 173 | MP0004858_abnormal_nervous_system | 0.72229184 |
| 174 | MP0000015_abnormal_ear_pigmentation | 0.70696215 |
| 175 | MP0003119_abnormal_digestive_system | 0.70271945 |
| 176 | MP0006276_abnormal_autonomic_nervous | 0.70063224 |
| 177 | MP0000377_abnormal_hair_follicle | 0.69696265 |
| 178 | MP0003959_abnormal_lean_body | 0.69544860 |
| 179 | MP0004085_abnormal_heartbeat | 0.69145567 |
| 180 | MP0004782_abnormal_surfactant_physiolog | 0.65890191 |
| 181 | MP0002971_abnormal_brown_adipose | 0.64540483 |
| 182 | MP0003724_increased_susceptibility_to | 0.61982005 |
| 183 | MP0002972_abnormal_cardiac_muscle | 0.61309282 |
| 184 | MP0005257_abnormal_intraocular_pressure | 0.57422319 |
| 185 | MP0000470_abnormal_stomach_morphology | 0.57243204 |
| 186 | MP0005319_abnormal_enzyme/_coenzyme | 0.57238991 |
| 187 | MP0005332_abnormal_amino_acid | 0.56074540 |
| 188 | MP0002751_abnormal_autonomic_nervous | 0.56017567 |
| 189 | MP0000639_abnormal_adrenal_gland | 0.55346944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 6.92386113 |
| 2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 6.74487965 |
| 3 | Hypoglycemic seizures (HP:0002173) | 6.73861037 |
| 4 | Symptomatic seizures (HP:0011145) | 5.90070689 |
| 5 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.83907606 |
| 6 | Ketoacidosis (HP:0001993) | 4.70532935 |
| 7 | Cholecystitis (HP:0001082) | 4.14971203 |
| 8 | Abnormal gallbladder physiology (HP:0012438) | 4.14971203 |
| 9 | Late onset (HP:0003584) | 4.14250980 |
| 10 | Hyperglycemia (HP:0003074) | 4.01634284 |
| 11 | Thoracolumbar scoliosis (HP:0002944) | 3.95034004 |
| 12 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.82147278 |
| 13 | Generalized aminoaciduria (HP:0002909) | 3.81938624 |
| 14 | Prolonged bleeding time (HP:0003010) | 3.77918684 |
| 15 | Short middle phalanx of the 5th finger (HP:0004220) | 3.76955351 |
| 16 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.67721357 |
| 17 | Poikilocytosis (HP:0004447) | 3.62754245 |
| 18 | Popliteal pterygium (HP:0009756) | 3.57589215 |
| 19 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.55814418 |
| 20 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.55712560 |
| 21 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.55712560 |
| 22 | Papillary thyroid carcinoma (HP:0002895) | 3.48080873 |
| 23 | Acute myeloid leukemia (HP:0004808) | 3.46824567 |
| 24 | Pheochromocytoma (HP:0002666) | 3.45416096 |
| 25 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.42110933 |
| 26 | Ketosis (HP:0001946) | 3.38816119 |
| 27 | Conjugated hyperbilirubinemia (HP:0002908) | 3.29002271 |
| 28 | Peripheral hypomyelination (HP:0007182) | 3.28585009 |
| 29 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.20957865 |
| 30 | Abnormal gallbladder morphology (HP:0012437) | 3.17099263 |
| 31 | Increased mean platelet volume (HP:0011877) | 3.16951384 |
| 32 | Petechiae (HP:0000967) | 3.12200250 |
| 33 | Neuroendocrine neoplasm (HP:0100634) | 3.11218093 |
| 34 | Large for gestational age (HP:0001520) | 3.10591795 |
| 35 | Hypothermia (HP:0002045) | 2.97829170 |
| 36 | Hyperbilirubinemia (HP:0002904) | 2.96297717 |
| 37 | Cholelithiasis (HP:0001081) | 2.91211494 |
| 38 | Thyroid carcinoma (HP:0002890) | 2.88922964 |
| 39 | Absent eyebrow (HP:0002223) | 2.86938984 |
| 40 | Neoplasm of the adrenal cortex (HP:0100641) | 2.86431941 |
| 41 | Exercise-induced muscle cramps (HP:0003710) | 2.85699788 |
| 42 | Birth length less than 3rd percentile (HP:0003561) | 2.84490404 |
| 43 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.83692651 |
| 44 | Biliary tract neoplasm (HP:0100574) | 2.81011580 |
| 45 | Cortical dysplasia (HP:0002539) | 2.78538497 |
| 46 | Abnormal platelet volume (HP:0011876) | 2.75599905 |
| 47 | Curly hair (HP:0002212) | 2.75321318 |
| 48 | Tetraparesis (HP:0002273) | 2.73183320 |
| 49 | Cutaneous finger syndactyly (HP:0010554) | 2.72254864 |
| 50 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.71286974 |
| 51 | Mucopolysacchariduria (HP:0008155) | 2.71286974 |
| 52 | Long clavicles (HP:0000890) | 2.67207896 |
| 53 | Abnormal pancreas size (HP:0012094) | 2.65150807 |
| 54 | Abnormality of the intrinsic pathway (HP:0010989) | 2.64588181 |
| 55 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.62517399 |
| 56 | Submucous cleft hard palate (HP:0000176) | 2.61235123 |
| 57 | Dysostosis multiplex (HP:0000943) | 2.59660607 |
| 58 | Insulin resistance (HP:0000855) | 2.56549340 |
| 59 | Nemaline bodies (HP:0003798) | 2.54833679 |
| 60 | Decreased circulating renin level (HP:0003351) | 2.54383848 |
| 61 | Neoplasm of the small intestine (HP:0100833) | 2.53725220 |
| 62 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.50932166 |
| 63 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.50932166 |
| 64 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.50932166 |
| 65 | Difficulty running (HP:0009046) | 2.50396234 |
| 66 | Muscle fiber inclusion bodies (HP:0100299) | 2.50076540 |
| 67 | Agitation (HP:0000713) | 2.44067985 |
| 68 | Intrahepatic cholestasis (HP:0001406) | 2.43257008 |
| 69 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.36044690 |
| 70 | Neoplasm of the adrenal gland (HP:0100631) | 2.34734370 |
| 71 | Capillary hemangiomas (HP:0005306) | 2.34565027 |
| 72 | Abnormal platelet function (HP:0011869) | 2.33115210 |
| 73 | Impaired platelet aggregation (HP:0003540) | 2.33115210 |
| 74 | Rimmed vacuoles (HP:0003805) | 2.32971441 |
| 75 | Reticulocytosis (HP:0001923) | 2.30025857 |
| 76 | Abnormal large intestine physiology (HP:0012700) | 2.29280008 |
| 77 | Hyperkalemia (HP:0002153) | 2.27965886 |
| 78 | Glycosuria (HP:0003076) | 2.27820975 |
| 79 | Abnormality of urine glucose concentration (HP:0011016) | 2.27820975 |
| 80 | Myoglobinuria (HP:0002913) | 2.27260662 |
| 81 | Palpitations (HP:0001962) | 2.26204914 |
| 82 | Osteomalacia (HP:0002749) | 2.24913243 |
| 83 | Global brain atrophy (HP:0002283) | 2.24823631 |
| 84 | Absent eyelashes (HP:0000561) | 2.23988061 |
| 85 | Abnormality of the labia minora (HP:0012880) | 2.23738272 |
| 86 | Hypercortisolism (HP:0001578) | 2.22758646 |
| 87 | Cutaneous syndactyly (HP:0012725) | 2.22596046 |
| 88 | Spastic diplegia (HP:0001264) | 2.21061841 |
| 89 | Abnormality of the common coagulation pathway (HP:0010990) | 2.20603417 |
| 90 | Bowel incontinence (HP:0002607) | 2.20005528 |
| 91 | Gout (HP:0001997) | 2.19424207 |
| 92 | Acanthocytosis (HP:0001927) | 2.19087629 |
| 93 | Xanthomatosis (HP:0000991) | 2.18908397 |
| 94 | Increased density of long bones (HP:0006392) | 2.18652578 |
| 95 | Polycythemia (HP:0001901) | 2.16421099 |
| 96 | Hypobetalipoproteinemia (HP:0003563) | 2.15407305 |
| 97 | Areflexia of lower limbs (HP:0002522) | 2.14319635 |
| 98 | Multiple enchondromatosis (HP:0005701) | 2.14128874 |
| 99 | Visual hallucinations (HP:0002367) | 2.12096651 |
| 100 | Rhabdomyosarcoma (HP:0002859) | 2.11900558 |
| 101 | Abnormality of the gallbladder (HP:0005264) | 2.11754780 |
| 102 | Limb hypertonia (HP:0002509) | 2.11208785 |
| 103 | Hepatic necrosis (HP:0002605) | 2.11129302 |
| 104 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.10335996 |
| 105 | Hypokalemia (HP:0002900) | 2.09921694 |
| 106 | Bifid tongue (HP:0010297) | 2.09098168 |
| 107 | Homocystinuria (HP:0002156) | 2.08869406 |
| 108 | Abnormality of homocysteine metabolism (HP:0010919) | 2.08869406 |
| 109 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.07681536 |
| 110 | Calf muscle hypertrophy (HP:0008981) | 2.05676422 |
| 111 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.05128351 |
| 112 | Palmar hyperkeratosis (HP:0010765) | 2.04507256 |
| 113 | Hyperparathyroidism (HP:0000843) | 2.03482354 |
| 114 | Acute necrotizing encephalopathy (HP:0006965) | 2.02537603 |
| 115 | Septate vagina (HP:0001153) | 2.02394020 |
| 116 | Distal arthrogryposis (HP:0005684) | 2.02039194 |
| 117 | Acute lymphatic leukemia (HP:0006721) | 2.01859586 |
| 118 | Erythroderma (HP:0001019) | 2.01493367 |
| 119 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.00741792 |
| 120 | Gastrointestinal carcinoma (HP:0002672) | 2.00741792 |
| 121 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.98771876 |
| 122 | Asymmetric septal hypertrophy (HP:0001670) | 1.98684628 |
| 123 | Vacuolated lymphocytes (HP:0001922) | 1.97568667 |
| 124 | Postural tremor (HP:0002174) | 1.97145218 |
| 125 | Exercise-induced myalgia (HP:0003738) | 1.96729091 |
| 126 | Acute encephalopathy (HP:0006846) | 1.96440485 |
| 127 | Abnormality of magnesium homeostasis (HP:0004921) | 1.95871596 |
| 128 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.93334691 |
| 129 | Selective tooth agenesis (HP:0001592) | 1.93238405 |
| 130 | Long nose (HP:0003189) | 1.93217551 |
| 131 | Paralysis (HP:0003470) | 1.92973187 |
| 132 | Hypoplastic labia majora (HP:0000059) | 1.92669194 |
| 133 | Abnormality of potassium homeostasis (HP:0011042) | 1.92293695 |
| 134 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.92128264 |
| 135 | Subaortic stenosis (HP:0001682) | 1.92128264 |
| 136 | Dysautonomia (HP:0002459) | 1.91700613 |
| 137 | Prolonged partial thromboplastin time (HP:0003645) | 1.91700509 |
| 138 | Shoulder girdle muscle weakness (HP:0003547) | 1.90448604 |
| 139 | Hypomagnesemia (HP:0002917) | 1.89268757 |
| 140 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.88612090 |
| 141 | Dicarboxylic aciduria (HP:0003215) | 1.88612090 |
| 142 | Hyperphosphaturia (HP:0003109) | 1.87971459 |
| 143 | White forelock (HP:0002211) | 1.87317613 |
| 144 | Ovarian neoplasm (HP:0100615) | 1.86498519 |
| 145 | Right ventricular cardiomyopathy (HP:0011663) | 1.85970656 |
| 146 | Abnormality of nail color (HP:0100643) | 1.85894067 |
| 147 | Ventricular fibrillation (HP:0001663) | 1.85692866 |
| 148 | Abnormal protein glycosylation (HP:0012346) | 1.85390753 |
| 149 | Abnormal glycosylation (HP:0012345) | 1.85390753 |
| 150 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.85390753 |
| 151 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.85390753 |
| 152 | Neoplasm of the thyroid gland (HP:0100031) | 1.83396874 |
| 153 | Abdominal distention (HP:0003270) | 1.82996631 |
| 154 | Abnormal hair whorl (HP:0010721) | 1.82003162 |
| 155 | Abnormality of purine metabolism (HP:0004352) | 1.81508628 |
| 156 | Exocrine pancreatic insufficiency (HP:0001738) | 1.80806621 |
| 157 | Neoplasm of the colon (HP:0100273) | 1.80742434 |
| 158 | Retinal atrophy (HP:0001105) | 1.80146409 |
| 159 | Palmoplantar hyperkeratosis (HP:0000972) | 1.79971443 |
| 160 | Hypophosphatemia (HP:0002148) | 1.79054690 |
| 161 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.79017938 |
| 162 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.78192470 |
| 163 | Pelvic girdle muscle weakness (HP:0003749) | 1.77850510 |
| 164 | Abnormality of lateral ventricle (HP:0030047) | 1.77767744 |
| 165 | Patchy hypopigmentation of hair (HP:0011365) | 1.75580836 |
| 166 | Bladder carcinoma (HP:0002862) | 1.74963288 |
| 167 | Bladder neoplasm (HP:0009725) | 1.74963288 |
| 168 | Menstrual irregularities (HP:0000858) | 1.74869010 |
| 169 | Atrioventricular block (HP:0001678) | 1.74601354 |
| 170 | Neoplasm of the rectum (HP:0100743) | 1.74522658 |
| 171 | Progressive macrocephaly (HP:0004481) | 1.74275914 |
| 172 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.74219952 |
| 173 | Abnormality of the axillary hair (HP:0100134) | 1.73833090 |
| 174 | Abnormality of secondary sexual hair (HP:0009888) | 1.73833090 |
| 175 | Abnormal biliary tract morphology (HP:0012440) | 1.73420724 |
| 176 | Mask-like facies (HP:0000298) | 1.72901990 |
| 177 | Hepatoblastoma (HP:0002884) | 1.72784484 |
| 178 | Skin nodule (HP:0200036) | 1.72532990 |
| 179 | Conjunctival telangiectasia (HP:0000524) | 1.72120400 |
| 180 | Abnormality of the labia majora (HP:0012881) | 1.70136574 |
| 181 | Chromsome breakage (HP:0040012) | 1.69447392 |
| 182 | Medulloblastoma (HP:0002885) | 1.69032716 |
| 183 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.67992426 |
| 184 | Ankyloglossia (HP:0010296) | 1.67968181 |
| 185 | Spontaneous hematomas (HP:0007420) | 1.67672196 |
| 186 | Abnormality of the columella (HP:0009929) | 1.67332414 |
| 187 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.67017667 |
| 188 | Myelodysplasia (HP:0002863) | 1.66771620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 5.71125759 |
| 2 | MAP3K2 | 4.51005552 |
| 3 | PASK | 4.40513043 |
| 4 | MAPK15 | 3.14006399 |
| 5 | KDR | 3.13531057 |
| 6 | TAOK3 | 3.08628946 |
| 7 | HIPK2 | 2.95463744 |
| 8 | MKNK2 | 2.76215235 |
| 9 | STK24 | 2.73578684 |
| 10 | EPHA3 | 2.63731210 |
| 11 | MKNK1 | 2.61568587 |
| 12 | FRK | 2.44311979 |
| 13 | BMPR1B | 2.42282055 |
| 14 | CDC7 | 2.36282776 |
| 15 | ACVR1B | 2.34030296 |
| 16 | TTK | 2.30512029 |
| 17 | STK3 | 2.24909699 |
| 18 | CDK8 | 2.22220098 |
| 19 | ERN1 | 2.12130429 |
| 20 | EIF2AK1 | 2.03102727 |
| 21 | PLK4 | 2.02218397 |
| 22 | MAP3K1 | 2.00474905 |
| 23 | GRK5 | 1.89001958 |
| 24 | MST4 | 1.87833345 |
| 25 | FLT3 | 1.87568865 |
| 26 | MAP3K4 | 1.86964173 |
| 27 | TRIM28 | 1.83004160 |
| 28 | EEF2K | 1.77180688 |
| 29 | IRAK1 | 1.71505732 |
| 30 | BLK | 1.67384926 |
| 31 | CAMKK2 | 1.65484110 |
| 32 | WNK4 | 1.64405396 |
| 33 | BCKDK | 1.63253351 |
| 34 | PBK | 1.55921868 |
| 35 | RET | 1.55863130 |
| 36 | ZAK | 1.52687329 |
| 37 | PLK3 | 1.45651173 |
| 38 | NUAK1 | 1.44390602 |
| 39 | PRKD3 | 1.43590975 |
| 40 | MAPKAPK5 | 1.40935031 |
| 41 | YES1 | 1.39859175 |
| 42 | KSR2 | 1.37360544 |
| 43 | BRD4 | 1.34217263 |
| 44 | SCYL2 | 1.33869759 |
| 45 | EIF2AK3 | 1.33278229 |
| 46 | LMTK2 | 1.29104353 |
| 47 | NTRK1 | 1.25363082 |
| 48 | TSSK6 | 1.21965286 |
| 49 | MAP2K2 | 1.21144490 |
| 50 | WEE1 | 1.21113747 |
| 51 | PTK2B | 1.20394235 |
| 52 | ERBB3 | 1.19775000 |
| 53 | BMPR2 | 1.19085694 |
| 54 | BMX | 1.17125328 |
| 55 | MUSK | 1.15792638 |
| 56 | PINK1 | 1.14402124 |
| 57 | UHMK1 | 1.12722341 |
| 58 | RIPK4 | 1.11712049 |
| 59 | PIM1 | 1.10199586 |
| 60 | FGFR4 | 1.05924263 |
| 61 | JAK2 | 1.05568322 |
| 62 | DMPK | 1.04785683 |
| 63 | RAF1 | 1.04336169 |
| 64 | CAMK1G | 1.03791409 |
| 65 | PTK6 | 1.00731696 |
| 66 | TLK1 | 0.98690802 |
| 67 | EPHB1 | 0.98593585 |
| 68 | TRIB3 | 0.97839495 |
| 69 | PIK3CG | 0.97629466 |
| 70 | PIM2 | 0.96912847 |
| 71 | CDK6 | 0.96820556 |
| 72 | SIK1 | 0.95944432 |
| 73 | NTRK3 | 0.95865636 |
| 74 | STK38L | 0.95391591 |
| 75 | NLK | 0.91907376 |
| 76 | PTK2 | 0.90084005 |
| 77 | MAP2K7 | 0.90059318 |
| 78 | BRSK2 | 0.89881728 |
| 79 | ATM | 0.89780253 |
| 80 | MAP3K10 | 0.89121963 |
| 81 | CSNK1G1 | 0.89070990 |
| 82 | PLK2 | 0.88810031 |
| 83 | TESK1 | 0.88220604 |
| 84 | TRPM7 | 0.87557879 |
| 85 | PLK1 | 0.86773436 |
| 86 | MAP3K11 | 0.86000158 |
| 87 | FGFR3 | 0.84763463 |
| 88 | RPS6KA4 | 0.83457820 |
| 89 | LATS1 | 0.80276497 |
| 90 | KSR1 | 0.79857136 |
| 91 | MAP3K3 | 0.79623296 |
| 92 | ATR | 0.75623320 |
| 93 | PRKCE | 0.74246180 |
| 94 | ARAF | 0.73884759 |
| 95 | PDGFRA | 0.73720752 |
| 96 | TAF1 | 0.72498490 |
| 97 | SGK2 | 0.71456105 |
| 98 | RPS6KA2 | 0.71193870 |
| 99 | PNCK | 0.70277420 |
| 100 | RPS6KB1 | 0.70142008 |
| 101 | PAK3 | 0.69007282 |
| 102 | FGFR2 | 0.68018610 |
| 103 | ERBB4 | 0.67979794 |
| 104 | PRKD1 | 0.67459068 |
| 105 | TGFBR1 | 0.67158043 |
| 106 | SRPK1 | 0.66367739 |
| 107 | CDC42BPA | 0.64809332 |
| 108 | RPS6KB2 | 0.62122226 |
| 109 | PRKCH | 0.61234191 |
| 110 | MAPK11 | 0.60834713 |
| 111 | CDK3 | 0.60356731 |
| 112 | PRKACG | 0.59560258 |
| 113 | TEC | 0.59082172 |
| 114 | DYRK3 | 0.59012814 |
| 115 | PRKAA1 | 0.58921605 |
| 116 | PHKG2 | 0.58369139 |
| 117 | PHKG1 | 0.58369139 |
| 118 | DYRK1B | 0.56299482 |
| 119 | MAP2K1 | 0.55552014 |
| 120 | MAP3K6 | 0.55483475 |
| 121 | TNIK | 0.54510834 |
| 122 | TESK2 | 0.53895995 |
| 123 | JAK1 | 0.53742831 |
| 124 | CHEK2 | 0.53351582 |
| 125 | CHEK1 | 0.53066917 |
| 126 | NEK2 | 0.52550575 |
| 127 | FER | 0.51860298 |
| 128 | CAMK2D | 0.51636032 |
| 129 | IRAK3 | 0.50313283 |
| 130 | STK4 | 0.49971130 |
| 131 | IRAK2 | 0.49587353 |
| 132 | MAPK13 | 0.48189537 |
| 133 | BRAF | 0.46959644 |
| 134 | BUB1 | 0.46865907 |
| 135 | MAPK10 | 0.46470156 |
| 136 | PRKG2 | 0.46450578 |
| 137 | ALK | 0.46228502 |
| 138 | TIE1 | 0.45744090 |
| 139 | CLK1 | 0.45445824 |
| 140 | CAMK1D | 0.44825595 |
| 141 | SGK3 | 0.44649013 |
| 142 | TYK2 | 0.44403135 |
| 143 | MARK3 | 0.43991930 |
| 144 | MAPK12 | 0.43797992 |
| 145 | SGK223 | 0.42876666 |
| 146 | SGK494 | 0.42876666 |
| 147 | MET | 0.42715074 |
| 148 | CSNK1G2 | 0.42588101 |
| 149 | FES | 0.41826692 |
| 150 | CDK2 | 0.41640213 |
| 151 | ZAP70 | 0.41201962 |
| 152 | PRKAA2 | 0.40775144 |
| 153 | PRKACA | 0.40442133 |
| 154 | CDK1 | 0.39819739 |
| 155 | SIK3 | 0.39090115 |
| 156 | CSNK1E | 0.38869528 |
| 157 | WNK1 | 0.38761550 |
| 158 | MAPKAPK3 | 0.38444226 |
| 159 | ITK | 0.38189150 |
| 160 | GSK3A | 0.35136637 |
| 161 | CAMKK1 | 0.34334553 |
| 162 | EIF2AK2 | 0.33452539 |
| 163 | MST1R | 0.33156513 |
| 164 | NEK1 | 0.32981681 |
| 165 | JAK3 | 0.32686614 |
| 166 | MAPK7 | 0.31852897 |
| 167 | PRKDC | 0.31755322 |
| 168 | LIMK1 | 0.30350752 |
| 169 | TBK1 | 0.29848683 |
| 170 | IGF1R | 0.28597200 |
| 171 | OBSCN | 0.28569849 |
| 172 | CDK5 | 0.28243056 |
| 173 | STK16 | 0.26439887 |
| 174 | CAMK2G | 0.23190236 |
| 175 | MAP4K1 | 0.22111018 |
| 176 | RIPK1 | 0.21286929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.82283866 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 6.69726526 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.85289898 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.47867848 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 3.14672107 |
| 6 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.67527950 |
| 7 | Insulin secretion_Homo sapiens_hsa04911 | 2.32748460 |
| 8 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.19307696 |
| 9 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.06531621 |
| 10 | Cell cycle_Homo sapiens_hsa04110 | 2.00622117 |
| 11 | DNA replication_Homo sapiens_hsa03030 | 2.00456989 |
| 12 | * Platelet activation_Homo sapiens_hsa04611 | 1.99681373 |
| 13 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.94742449 |
| 14 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.92841806 |
| 15 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.83662800 |
| 16 | Galactose metabolism_Homo sapiens_hsa00052 | 1.78996286 |
| 17 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.77109929 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.76769094 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.71455394 |
| 20 | RNA transport_Homo sapiens_hsa03013 | 1.56610287 |
| 21 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.53480425 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.51518409 |
| 23 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.49601903 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.40388135 |
| 25 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.39818859 |
| 26 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.36824480 |
| 27 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.35309791 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.34185793 |
| 29 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.32418164 |
| 30 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.30965426 |
| 31 | Long-term depression_Homo sapiens_hsa04730 | 1.30007301 |
| 32 | ABC transporters_Homo sapiens_hsa02010 | 1.28550627 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.28077508 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.26801893 |
| 35 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.24558045 |
| 36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.22247613 |
| 37 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.21479420 |
| 38 | Homologous recombination_Homo sapiens_hsa03440 | 1.17240542 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.16026118 |
| 40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.12696371 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.12635365 |
| 42 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.12421286 |
| 43 | Basal transcription factors_Homo sapiens_hsa03022 | 1.09428118 |
| 44 | Spliceosome_Homo sapiens_hsa03040 | 1.08430234 |
| 45 | Lysosome_Homo sapiens_hsa04142 | 1.08204869 |
| 46 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.08039668 |
| 47 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.07966309 |
| 48 | Histidine metabolism_Homo sapiens_hsa00340 | 1.06672462 |
| 49 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.05905770 |
| 50 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.05124242 |
| 51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.04444144 |
| 52 | Insulin resistance_Homo sapiens_hsa04931 | 1.02073924 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.01760143 |
| 54 | RNA degradation_Homo sapiens_hsa03018 | 1.01467915 |
| 55 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.01128890 |
| 56 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.00065577 |
| 57 | Adherens junction_Homo sapiens_hsa04520 | 0.99487878 |
| 58 | Other glycan degradation_Homo sapiens_hsa00511 | 0.98004826 |
| 59 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.96240086 |
| 60 | Long-term potentiation_Homo sapiens_hsa04720 | 0.91578801 |
| 61 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.90827890 |
| 62 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90716864 |
| 63 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.88502583 |
| 64 | Parkinsons disease_Homo sapiens_hsa05012 | 0.88011298 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87785902 |
| 66 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.87760391 |
| 67 | Circadian rhythm_Homo sapiens_hsa04710 | 0.87082969 |
| 68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85930503 |
| 69 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.85237513 |
| 70 | Cocaine addiction_Homo sapiens_hsa05030 | 0.85097220 |
| 71 | Gap junction_Homo sapiens_hsa04540 | 0.84256609 |
| 72 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.83368262 |
| 73 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.83359502 |
| 74 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.82814819 |
| 75 | Bile secretion_Homo sapiens_hsa04976 | 0.82126427 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80360370 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.79622324 |
| 78 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79040129 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78661947 |
| 80 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.78241419 |
| 81 | Renin secretion_Homo sapiens_hsa04924 | 0.77430820 |
| 82 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.75775768 |
| 83 | Prostate cancer_Homo sapiens_hsa05215 | 0.75435995 |
| 84 | Alzheimers disease_Homo sapiens_hsa05010 | 0.74585384 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73860826 |
| 86 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.73534669 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73027694 |
| 88 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.71885352 |
| 89 | Olfactory transduction_Homo sapiens_hsa04740 | 0.71865183 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71631537 |
| 91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.71204493 |
| 92 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70901862 |
| 93 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.68977527 |
| 94 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.67304925 |
| 95 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.67218693 |
| 96 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.65395544 |
| 97 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.65344885 |
| 98 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.65222397 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64063904 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61133533 |
| 101 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.60218099 |
| 102 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.60138714 |
| 103 | * Taste transduction_Homo sapiens_hsa04742 | 0.59813043 |
| 104 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58968984 |
| 105 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58645260 |
| 106 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.58130503 |
| 107 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.58019595 |
| 108 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57885125 |
| 109 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.57716094 |
| 110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56492139 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.55539383 |
| 112 | Purine metabolism_Homo sapiens_hsa00230 | 0.55153031 |
| 113 | Colorectal cancer_Homo sapiens_hsa05210 | 0.55033367 |
| 114 | Thyroid cancer_Homo sapiens_hsa05216 | 0.54962606 |
| 115 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54331075 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53951954 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53067225 |
| 118 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52745107 |
| 119 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50112031 |
| 120 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.48801464 |
| 121 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48638839 |
| 122 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48117394 |
| 123 | Alcoholism_Homo sapiens_hsa05034 | 0.48007350 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45391617 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44961241 |
| 126 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.44885002 |
| 127 | Tight junction_Homo sapiens_hsa04530 | 0.44844671 |
| 128 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43869042 |
| 129 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.43607493 |
| 130 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.43108193 |
| 131 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42798993 |
| 132 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.41892084 |
| 133 | Lysine degradation_Homo sapiens_hsa00310 | 0.40961227 |
| 134 | Mineral absorption_Homo sapiens_hsa04978 | 0.39930943 |
| 135 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.39646098 |
| 136 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.39048163 |
| 137 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.36433309 |
| 138 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.36198714 |
| 139 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.35116965 |
| 140 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.33844448 |
| 141 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32398666 |
| 142 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.32153766 |
| 143 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31965556 |
| 144 | Phagosome_Homo sapiens_hsa04145 | 0.29377032 |
| 145 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.28341730 |
| 146 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.28173270 |
| 147 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.27464921 |
| 148 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25270479 |
| 149 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.24383669 |
| 150 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.23542303 |
| 151 | Carbon metabolism_Homo sapiens_hsa01200 | 0.22886982 |
| 152 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.22358086 |
| 153 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.19981388 |
| 154 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.19802153 |
| 155 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.19327873 |
| 156 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.18162397 |
| 157 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.18141409 |
| 158 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.18081388 |
| 159 | Circadian entrainment_Homo sapiens_hsa04713 | 0.17414824 |
| 160 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.17389390 |
| 161 | Huntingtons disease_Homo sapiens_hsa05016 | 0.17213322 |
| 162 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14721607 |

